ONO-4641

· Ono Pharma USA Inc

Drug timelines are a Plus or Pro feature.

1 regulatory and trial event tracked for ONO-4641, covering 2013-12-25 to 2013-12-25. Get the full timeline:

Most recent: Clinical Trial Update: A Study of the Safety and Efficacy of ONO-4641 in Patients With Relapsing-Remitting Multiple Sclerosis [Phase 2]